Professor Ian Frazer


Faculty of Medicine

Affiliate Professor

The University of Queensland Diamantina Institute
Faculty of Medicine

Affil Professorial Research Fellow

Institute for Molecular Bioscience
+61 7 344 38042


Professor Frazer's current research interests include immunoregulation and immunotherapeutic vaccines for papillomavirus associated cancers.

Professor Ian Frazer was trained as a renal physician and clinical immunologist in Edinburgh, Scotland before emigrating in 1980 to Melbourne, Australia to pursue studies in viral immunology and autoimmunity at the Walter and Eliza Hall Institute of Medical Research with Prof Ian Mackay. In 1985 he moved to Brisbane to take up a teaching post with the University of Queensland, and he now holds a personal chair as head of the Diamantina Institute.

Professor Frazer holds research funding from several Australian and US funding bodies. He is a director of a biotechnology start-up company, Coridon, with an interest in optimising and targeting polynucleotide vaccine protein expression. He is president of Cancer Council Australia, and advises the World Health Organisation and the Bill and Melinda Gates Foundation on papillomavirus vaccines. He won the 2005 CSIRO Eureka Prize for Leadership in Science, the Australian of the Year in 2006, and the Prime Minister's Prize for Science in 2008. Professor Frazer teaches immunology to undergraduate and graduate students of The University.


  • Doctor of Medicine, University of Melbourne
  • FRCP (Ed)
  • MB ChB, University of Edinburgh
  • Bachelor of Science (Honours), University of Edinburgh


View all Publications


View all Grants


View all Supervision



Book Chapter

  • Frazer, Ian H. (2010). Human papillomaviruses. In Andrew W. Artenstein (Ed.), Vaccines: a biography (pp. 361-373) New York, United States: Springer. doi:10.1007/978-1-4419-1108-7_21

  • Jansen, Kathrin U. and Frazer, Ian H. (2010). Vaccines against human papillomaviruses. In Myron M. Levine (Ed.), New generation vaccines 4th ed. (pp. 954-961) New York, U.S.A.: Informa Healthcare.

  • Frazer, Ian H. (2009). Vaccines against human papillomavirus infection. In Levine, M. M (Ed.), Vaccines against human papillomavirus infection 4th ed. (pp. 977-986) United States: Informa Healthcare.

  • Frazer, I.H. and Appleton. S. (2007). Vaccines to prevent and treat human papillomavirus associated anogenital disease. In Jordan, J., Singer, A. and et al. (Ed.), The Cervix (pp. 609-621) United States: Blackwell publishing.

  • Edwards, S. J., Basser, R. L. and Frazer, I. H. (2005). Development of a Vaccine Against Human Papillomavirus (HPV. In Philippe Moingeon Stallergenes (Ed.), Vaccines: Frontiers in Design and Development (pp. 210-230) United Kingdom: Horizon Bioscience.

  • Frazer, I. H. (2004). Human Papillomavirus. In Ciro A. de Quadros (Ed.), Vaccines: Preventing Disease & Protecting Health 1 ed. (pp. 140-143) Washington, D.C.: Pan American Health Organisation.

  • Boslego, J., Liu, X. and Frazer, I. H. (2004). Vaccines Against Human Papillomavirus Infection. In Myron M. Levine, James B. Kaper, Rino Rappuoli, Margaret A. Liu and Michael F. Good (Ed.), New Generation Vaccines 3 ed. (pp. 977-986) New York: Marcel Dekker, Inc..

  • Frazer, I. H. (2001). Wart and hepatitis vaccines. In D. L. Healy, R. McLachlan, G. T. Kovacs and O. Rodriguex-Armas (Ed.), Reproductive medicine in the twenty first century 1st ed. (pp. 173-181) UK: The Parthenon Publishing Group Ltd.

  • Frazer, I. H. and Tindle, R. (1999). Cell mediated immunity to papillomaviruses. In Charles Lacey (Ed.), Current research on papillomaviruses (pp. 151-164) Leeds, England: Leeds University Press.

  • Leggatt, G. R. and Frazer, I. H. (1999). Immunology of HPV infection. In Robert W. Tindle (Ed.), Vaccines for Human Papillomavirus Infection and Anogenital Disease (pp. 13-31) Austin, USA: R. G. Landes Company.

  • Frazer, I. H. and Dunn, L. A. (1999). Papillomavirus. In Rafi Ahmed and Irvin S.Y. Chen (Ed.), Persistent Viral Infections (pp. 131-146) Chichester, USA: John Wiley & Sons.

  • Frazer, I. H., Tindle, R. W., Fernando, G. J., Malcolm, K. M., Herd, K. A., McFadyen, S. M., Cooper, P. D. and Ward, B. G. (1999). Safety and Immunogenicity of HPV16 E7/Algammulin. In R. W. Tindle (Ed.), Vaccines for Human Papillomavirus Infection and Anogenital Disease (pp. 91-104) Austin, USA: R.G. Landes Company.

Journal Article

Conference Publication

Edited Outputs

Other Outputs

Grants (Administered at UQ)

PhD and MPhil Supervision

Current Supervision

  • Doctor Philosophy — Principal Advisor

  • Doctor Philosophy — Principal Advisor

  • Doctor Philosophy — Principal Advisor

  • Doctor Philosophy — Principal Advisor

    Other advisors:

Completed Supervision